"S2-2 STRATEGIC PROPOSALS TO AVOID DRUG INTERACTIONS DURING DRUG DEVELOPMENT : A LESSON FROM A TERFENADINE-RELATED DRUG INTERACTION (<SYMPOSIUM 2>Strategy how we can learn drug-drug interaction during the development of a new drug)
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 1996-12-20
著者
-
Ishizaki T
Kumamoto Univ. Kumamoto Jpn
-
ISHIZAKI Takashi
Chairman, Department of Clinical Pharmacology, Research Institute, International Medical Center of J
-
Ph.D. M.D.
Chairman, Department of Clinical Pharmacology, Research Institute, International Medical Center of J
-
Ishizaki Takashi
Division Of Drug Metabolism And Disposition Department Of Clinical Pharmacology Research Institute I
-
Ph.d. M.d.
Chairman Department Of Clinical Pharmacology Research Institute International Medical Center Of Japa
関連論文
- A Novel Single Nucleotide Polymorphism (SNP) of the CYP2C19 Gene in a Japanese Subject with Lowered Capacity of Mephobarbital 4'-Hydroxylation
- Development and preliminary application of high-performance liquid chromatographic assay of urinary metabolites of diazepam in humans
- EFFECTS OF N-METHYLMERCAPTOIMIDAZOLE AND THE STRAIN DIFFERENCE ON THE DISPOSITION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN MICE
- "S2-2 STRATEGIC PROPOSALS TO AVOID DRUG INTERACTIONS DURING DRUG DEVELOPMENT : A LESSON FROM A TERFENADINE-RELATED DRUG INTERACTION (Strategy how we can learn drug-drug interaction during the development of a new drug)